| Driver fusions and their implications in the development and treatment of human cancers Q Gao, WW Liang, SM Foltz, G Mutharasu, RG Jayasinghe, S Cao, ... Cell reports 23 (1), 227-238. e3, 2018 | 483 | 2018 |
| Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma MA Gillette, S Satpathy, S Cao, SM Dhanasekaran, SV Vasaikar, K Krug, ... Cell 182 (1), 200-225. e35, 2020 | 465 | 2020 |
| Proteogenomic and metabolomic characterization of human glioblastoma LB Wang, A Karpova, MA Gritsenko, JE Kyle, S Cao, Y Li, D Rykunov, ... Cancer cell 39 (4), 509-528. e20, 2021 | 395 | 2021 |
| Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma C Huang, L Chen, SR Savage, RV Eguez, Y Dou, Y Li, ... Cancer cell 39 (3), 361-379. e16, 2021 | 222 | 2021 |
| Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts XY Woo, J Giordano, A Srivastava, ZM Zhao, MW Lloyd, R de Bruijn, ... Nature genetics 53 (1), 86-99, 2021 | 151 | 2021 |
| Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer D Cui Zhou, RG Jayasinghe, S Chen, JM Herndon, MD Iglesia, P Navale, ... Nature genetics 54 (9), 1390-1405, 2022 | 89 | 2022 |
| Co-evolution of tumor and immune cells during progression of multiple myeloma R Liu, Q Gao, SM Foltz, JS Fowles, L Yao, JT Wang, S Cao, H Sun, ... Nature communications 12 (1), 2559, 2021 | 85 | 2021 |
| Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment H Sun, S Cao, RJ Mashl, CK Mo, S Zaccaria, MC Wendl, SR Davies, ... Nature communications 12 (1), 5086, 2021 | 72 | 2021 |
| ZFX acts as a transcriptional activator in multiple types of human tumors by binding downstream from transcription start sites at the majority of CpG island promoters SK Rhie, L Yao, Z Luo, H Witt, S Schreiner, Y Guo, AA Perez, PJ Farnham Genome research 28 (3), 310-320, 2018 | 62 | 2018 |
| Evolution and structure of clinically relevant gene fusions in multiple myeloma SM Foltz, Q Gao, CJ Yoon, H Sun, L Yao, Y Li, RG Jayasinghe, S Cao, ... Nature communications 11 (1), 2666, 2020 | 38 | 2020 |
| Isotope tracing in adult zebrafish reveals alanine cycling between melanoma and liver FJ Naser, MM Jackstadt, R Fowle-Grider, JL Spalding, K Cho, E Stancliffe, ... Cell metabolism 33 (7), 1493-1504. e5, 2021 | 29 | 2021 |
| Proteogenomic data and resources for pan-cancer analysis Y Li, Y Dou, FDV Leprevost, Y Geffen, AP Calinawan, F Aguet, Y Akiyama, ... Cancer cell 41 (8), 1397-1406, 2023 | 24 | 2023 |
| Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation Y Geffen, S Anand, Y Akiyama, TM Yaron, Y Song, JL Johnson, ... Cell 186 (18), 3945-3967. e26, 2023 | 18 | 2023 |
| Clinical Proteomic Tumor Analysis Consortium Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma MA Gillette, S Satpathy, S Cao, SM Dhanasekaran, SV Vasaikar, K Krug, ... Cell 182 (1), 200-225, 2020 | 18 | 2020 |
| Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma Y Wu, NV Terekhanova, W Caravan, N Naser Al Deen, P Lal, S Chen, ... Nature communications 14 (1), 1681, 2023 | 15 | 2023 |
| Cross center single-cell RNA sequencing study of the immune microenvironment in rapid progressing multiple myeloma W Pilcher, BE Thomas, SS Bhasin, RG Jayasinghe, L Yao, ... npj Genomic Medicine 8 (1), 3, 2023 | 14 | 2023 |
| Spatial drivers and pre-cancer populations collaborate with the microenvironment in untreated and chemo-resistant pancreatic cancer DC Zhou, RG Jayasinghe, JM Herndon, E Storrs, CK Mo, Y Wu, RS Fulton, ... BioRxiv, 2021.01. 13.426413, 2021 | 13 | 2021 |
| Comprehensive characterization of the multiple myeloma immune microenvironment using integrated scRNA-seq, CyTOF, and CITE-seq analysis L Yao, RG Jayasinghe, BH Lee, SS Bhasin, W Pilcher, DB Doxie, ... Cancer Research Communications 2 (10), 1255-1265, 2022 | 12 | 2022 |
| Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin WW Liang, RJH Lu, RG Jayasinghe, SM Foltz, E Porta-Pardo, Y Geffen, ... Cancer cell 41 (9), 1567-1585. e7, 2023 | 8 | 2023 |
| Single-cell discovery and multiomic characterization of therapeutic targets in multiple myeloma L Yao, JT Wang, RG Jayasinghe, J O'Neal, CF Tsai, MP Rettig, Y Song, ... Cancer research 83 (8), 1214-1233, 2023 | 8 | 2023 |
